Proteins involved in the inflammatory response, such as FGF23, KITLG, and plasminogen activator, urokinase (PLAU), were found at lower levels in individuals without AMS than in those with AMS, but CCL2 was not significant in any of the compared groups (Supplementary Fig. 10b). The gene discussed is CCL2; the disease is ablepharon macrostomia syndrome.